12/31/2019NMPA Announces Initiation of Drug Business Application System

12/31/2019NMPA Issues Guiding Principles for Classification Standards for ADRs o...

12/30/2019Bankrupt Achaogen Sells China Assets to Xuanzhu for $4.5M

12/30/2019China's 'Seaweed' Alzheimer's Drug Is Now Available to Patients

12/30/2019NMPA Issues the Principles and Procedures for Drug Sampling

12/30/2019Boehringer Ingelheim Approved to Manufacture Tislelizumab in China for...

12/29/2019Document for New Round of National Level Centralized Drug Purchase Tri...

12/29/2019China Adopts New Law to Promote Basic Medical and Health Care

12/27/2019Recent Executive Moves

12/27/2019China Launches Mental Health Initiative for Students

12/27/2019Luye Pharma Submits New Drug Application in the U.S. for Its Antidepre...

12/27/2019Bridge and Daewoong Announces NMPA Clearance of IND for BBT-401, a Pel...

12/27/2019Zai Lab Announces NMPA Approval of ZEJULA (Niraparib) as Maintenance T...

12/27/2019JT and Salubris Pharma Enter Licensing Pact for HIF-PHI Inhibitor Enar...

12/27/2019NMPA Initiates Drug Import & Export Permit Management System

12/27/2019Janssen Secured Chinese Approval of Psoriasis Drug Tremfya (Gussetizum...

12/26/2019Sanofi Files NDA for the World's Atopic Dermatitis Biologic Dupilumab ...

12/26/2019CStone Pharma to Submit NDA for Anticancer Pralsetinib Next Year

12/26/2019China Lists Lemazolam for Regulation as Class 2 Psychotropic

12/25/2019CDE Solicits Comments on Guidelines for Clinical Protocol of Biosimila...

12/23/2019NMPA Issues the Technical Guidelines for Clinical Comparability Studie...

12/23/2019BeiGene Announces Acceptance of a China sNDA for REVLIMID in Relapsed ...

12/23/2019Chinese Medical Researcher Investigated for Smuggling Vials of Biologi...

12/23/2019AZ's Triple-Combination Therapy Approved in China

12/23/2019Amid Trade War, China Lowers Import Tariffs on 850 Products Including ...

12/23/2019Roche Eyes China for Sarepta's DMD Gene Therapy

12/20/2019Chi-Med Gets Priority Review for 'Surufatinib' in China

12/20/2019Gilead Sciences Announces Chinese Approval of Chronic HCV Drug Vosevi

12/20/2019InxMed Cleared to Initiate Phase I Trial for Anticancer FAK Inhibitor

12/20/2019China's Largest Plasmid and Virus Facility from GenScript Operational

Page:253/774 Total number of articles:23207: [First][<<] [251] [252] [253] [254] [255] [>>] [End]